Upgrade to SI Premium - Free Trial

Alpha Tau Medical (DRTS)

15.03 +0.41 (2.80%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/24/26)

Latest Headlines

Alpha Tau Medical Ltd. (DRTS) PT Raised to $30 at Barclays September 3, 2026 4:13 AM - StreetInsider H.C. Wainwright Reiterates Buy Rating on Alpha Tau Medical Ltd. (DRTS) September 1, 2026 7:15 AM - StreetInsider Form 4 Alpha Tau Medical Ltd. For: Aug 21 Filed by: Levy Raphi August 25, 2026 10:34 AM - SEC Filing Form 144 Alpha Tau Medical Ltd. Filed by: Levy Raphi August 21, 2026 5:01 PM - SEC Filing Nano Dimension names Nadav Kidron to board, to chair new committee August 17, 2026 8:01 AM - StreetInsider Nano Dimension Appoints Nadav Kidron to Board of Directors to Chair Strategy and Capital Allocation Committee August 17, 2026 8:00 AM - Globe NewsWire Form 4 Alpha Tau Medical Ltd. For: Aug 11 Filed by: Levy Raphi August 12, 2026 12:19 PM - SEC Filing Alpha Tau Medical Ltd. (DRTS) PT Raised to $16 at H.C. Wainwright August 12, 2026 7:21 AM - StreetInsider Alpha Tau Medical Ltd. (DRTS) Misses Q2 EPS by 12c August 10, 2026 5:35 PM - StreetInsider Form 6-K Alpha Tau Medical Ltd. For: Jun 30 August 10, 2026 4:03 PM - SEC Filing Alpha Tau Announces Second Quarter 2026 Financial Results and Provides Corporate Update August 10, 2026 4:01 PM - Globe NewsWire Form 6-K Alpha Tau Medical Ltd. For: Aug 10 August 10, 2026 8:00 AM - SEC Filing Alpha Tau Registers for Dual Listing on the Tel Aviv Stock Exchange (TASE) August 10, 2026 8:00 AM - Globe NewsWire H.C. Wainwright Reiterates Buy Rating on Alpha Tau Medical Ltd. (DRTS) July 23, 2026 7:12 AM - StreetInsider Alpha Tau reports 100% response rate in head and neck cancer combo trial July 21, 2026 8:32 AM - StreetInsider Form 6-K Alpha Tau Medical Ltd. For: Jul 21 July 21, 2026 8:30 AM - SEC Filing Alpha Tau Reports Positive Data Demonstrating 100% Objective Response Rate and 18.2-Month Median Overall Survival with Alpha DaRT® in Combination with Pembrolizumab in Locally Advanced or Metastatic July 21, 2026 8:30 AM - Globe NewsWire H.C. Wainwright Reiterates Buy Rating on Alpha Tau Medical Ltd. (DRTS) July 17, 2026 7:10 AM - StreetInsider Form 6-K Alpha Tau Medical Ltd. For: Jul 15 July 15, 2026 8:30 AM - SEC Filing Form 4 Alpha Tau Medical Ltd. For: Jul 06 Filed by: Levy Raphi July 7, 2026 7:49 AM - SEC Filing Form 144 Alpha Tau Medical Ltd. Filed by: Levy Raphi July 6, 2026 11:56 AM - SEC Filing Form 4 Alpha Tau Medical Ltd. For: Jul 02 Filed by: Levy Raphi July 6, 2026 11:37 AM - SEC Filing Form 4 Alpha Tau Medical Ltd. For: Jul 01 Filed by: Levy Raphi July 2, 2026 11:46 AM - SEC Filing Form 144 Alpha Tau Medical Ltd. Filed by: Levy Raphi July 2, 2026 6:32 AM - SEC Filing Form 4 Alpha Tau Medical Ltd. For: Jun 30 Filed by: Levy Raphi July 1, 2026 8:22 AM - SEC Filing Form 144 Alpha Tau Medical Ltd. Filed by: Levy Raphi June 30, 2026 11:34 AM - SEC Filing Form 4 Alpha Tau Medical Ltd. For: Jun 25 Filed by: Levy Raphi June 26, 2026 8:18 AM - SEC Filing Form 144 Alpha Tau Medical Ltd. Filed by: Levy Raphi June 26, 2026 6:45 AM - SEC Filing Form 6-K Alpha Tau Medical Ltd. For: Jun 25 June 25, 2026 4:01 PM - SEC Filing Oramed to join Russell indexes amid $270M balance sheet June 25, 2026 11:35 AM - StreetInsider Oramed Releases Letter to Shareholders, Highlighting Russell 2000/3000 Index Inclusion, Scilex Loan Repayment, Strategic Portfolio Appreciation, and a Strengthened Balance Sheet June 25, 2026 11:35 AM - PR NewsWire Form 4 Alpha Tau Medical Ltd. For: Jun 23 Filed by: Levy Raphi June 25, 2026 10:17 AM - SEC Filing Form 6-K Alpha Tau Medical Ltd. For: Jun 23 June 23, 2026 4:01 PM - SEC Filing Form 144 Alpha Tau Medical Ltd. Filed by: Levy Raphi June 23, 2026 6:13 AM - SEC Filing H.C. Wainwright Reiterates Buy Rating on Alpha Tau Medical Ltd. (DRTS) June 15, 2026 6:51 AM - StreetInsider Form 6-K Alpha Tau Medical Ltd. For: Jun 11 June 11, 2026 8:36 AM - SEC Filing Full Article List